Journal of Lipid Research launches junior associate editors program
This year, the Journal of Lipid Research welcomes its first cohort of junior associate editors.
Raymond Blind
Vanderbilt University
School of Medicine
Research area: Nuclear lipid signaling and structure
Mentor: George Carman
Gissette Reyes−Soffer
Columbia University
Irving Medical Center
Research area: Regulation and metabolism of Lipoprotein(a)
Mentor: Henry Ginsberg
Brandon Davies
University of Iowa
Carver College of Medicine
Research area: Lipid metabolism in endothelial cells
Mentor: Stephen Young
Rotonya Carr
University of Pennsylvania Perelman School of Medicine
Research area: Metabolism and lipid droplets in liver disease
Mentor: Nick Davidson
The four assistant professors, chosen from nominations made by the journal’s associate editors, are partnering with senior editors to learn how to manage the peer-review process.
“Engagement with the best and brightest young investigators in the lipid field is an investment in the future of JLR,” Co-Editor-in-Chief Kerry−Anne Rye said.
The new editors — two Ph.D.s and two M.D.s — already have accrued accolades and earned the community’s trust. Two are recipients of the JLR Junior Investigator Award. One won the Journal of Biological Chemistry/Herb Tabor Young Investigator Award. Another is on the Deuel Conference board.
Co-Editor-in-Chief Nicholas Davidson said the program’s mission is two-fold: “It’s demystifying the peer-review process and also teaching what we hope are going to be the next generation of full associate editors.”
The new editors are serving a two-year term from March 1, 2019, to Feb. 28, 2021.
They also will contribute a new type of article to the journal — commentaries on exciting lipid research published elsewhere.
Join the ASBMB Today mailing list
Sign up to get updates on articles, interviews and events.
Latest in Science
Science highlights or most popular articles
Brain Injury Awareness Month 2021
In the U.S., about 2.8 million people sustain a traumatic brain injury annually. Learn about recent research on TBI-related dementia, dysfunctional mitochondria and other work powering the march toward better therapies.
The evolution of proteins from mysteries to medicines
An essay in observance of National Protein Day.
'Every experiment and every breakthrough matters'
An interview with NYMC dean Marina K. Holz, who studies a rare disease that affects women of childbearing age.
Progeria: From the unknown to the first FDA-approved treatment
Hutchinson–Gilford progeria syndrome is a rare, fatal genetic disease that causes premature aging.
Raising awareness and funding for Pompe disease
Father-turned-advocate has founded multiple organizations to support families and search for better therapies for people with rare lysosomal storage disorder.
A novel approach to septic shock leads to a prospective new therapy
A French research team finds new evidence supporting endotoxin removal for treating life-threatening inflammation.